FDA Approves Two HPV Vaccines

Links shared publicly online about this topic.

  • 1,660
    total visits

FDA Approves Two HPV Vaccines

injuryboard.com

Cervarix has been approved for use in girls and women to fight cervical cancer the FDA announced on Friday the same day that Gardasil got approval for expanded use in boys and men to fight genital warts

View full resource at injuryboard.com

Tags: Children's Health, Men's Health, Women's Health, FDA, Vaccine, HPV Vaccine, Gardasil, Cervarix

  • Share

Most Recently Shared on October 21, 2009 at 9:26 pm By:

UTSWNews UT Southwestern News

2 #HPV vaccines okayed by #FDA. UTSW pediatric infectious disease expert comments on the decision. http://bit.ly/1NiIDZ

3 years ago...

Have you ever prescribed sipuleucel-T for a prostate cancer patient? - Renal and Urology News

renalandurologynews.com — “Nearly two years have passed since the FDA approved sipuleucel-T—a therapeutic cancer vaccine developed and marketed by Dendreon Corp.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 4:02 pm By:

FDA approves first quadrivalent vaccine to prevent seasonal influenza

fda.gov — “FluMist Quadrivalent, a vaccine to prevent seasonal influenza in people ages 2 years through 49 years, has been approved today by the U.S. Food and Drug Administration. FluMist Quadrivalent is the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on March 1, 2012 at 12:50 pm By:

wheezemd Michael Blaiss, MD Allergist, Physician, and Doctor

FDA approves first quadrivalent vaccine to prevent seasonal influenza http://t.co/LbwgqHoY

2 months ago...

The HPV Vaccine: Access and Use in the U.S. - Kaiser Family Foundation

kff.org — “The Food and Drug Administration has approved two vaccines against infection by certain strains of human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Initially, the vaccines were recommended only for girls and young women, but in 2011 the Centers for Disease Control and Prevention broadened them to include boys and young men. The fact sheet discusses HPV and cancers related to the virus, use of the HPV vaccines for both females and males, and insuranView full resource at kff.org

  • View Related
  • Share

Most Recently Shared on November 22, 2011 at 6:36 pm By:

HealthyAmerica1 TFAH Health Organization

HPV Vaccine Fact Sheet Discusses New Recommendation for Vaccinating Boys via KFF: http://t.co/4DpKQQdp

5 months ago...

NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome

medicalnewstoday.com — “A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a raView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 6, 2011 at 7:05 am By:

mnt_cervical MNT Cervical Cancer Health News

NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome http://mnt.to/3Zqx #cervicalcancer #hpv

8 months ago...

Mayo Clinic Receives FDA Approval for Ovarian and Breast Cancer Vaccines | Business Wire

businesswire.com — “Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body&rsView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on August 22, 2011 at 10:32 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Mayo Clinic Receives FDA Approval for Ovarian and Breast Cancer Vaccines: ROCHESTER, Minn.--(BUSINESS WIRE)--May... http://t.co/EgV30Yx

8 months ago...

FDA Approval For Ovarian And Breast Cancer Vaccines Received By Mayo Clinic

medicalnewstoday.com — “Mayo Clinic has received investigational new drug approval* from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cellsView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 19, 2011 at 8:05 am By:

mnt_ovariancanc MNT Ovarian Cancer Health News

FDA Approval For Ovarian And Breast Cancer Vaccines Received By Mayo Clinic http://mnt.to/3Z3F #ovariancancer

8 months ago...

Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines

medicalxpress.com — “Mayo Clinic has received investigational new drug approval from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells. The vaccines are among the first aimed at preventing cancer recurrence. The approval clears the way for ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on August 17, 2011 at 5:46 pm By:

physorg_health PhysOrg Health News Health News

Mayo Clinic receives FDA approval for ovarian and breast cancer vaccines http://t.co/j38V4kt

8 months ago...

Meningococcal Vaccine Now Approved for Use in Infants | Health News

healthnews.com — “Today the FDA approved the use of Menactra in children as young as nine months for the prevention of invasive meningococcal disease. While the vaccine has been previously available to people over the age of two, it is now approved for use in children as young as nine months.View full resource at healthnews.com

  • View Related
  • Share

Most Recently Shared on April 25, 2011 at 4:50 pm By:

HealthNewsUS Susan Brady Health News

Meningococcal Vaccine Now Approved for Use in Infants http://ht.ly/4Gv6g

1 year ago...

FDA approves Sanofi Pasteur's meningococcal vaccine

news-medical.net — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 25, 2011 at 11:44 am By:

Meningitis_News News-Medical.Net Health News

Meningitis News: FDA approves Sanofi Pasteur's meningococcal vaccine: Sanofi Pasteur, the vaccines division of t... http://bit.ly/eCrvvc

1 year ago...

FDA, Gardasil Approved To Prevent Anal Cancer

medicalnewstoday.com — “The U.S. Food and Drug Administration approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 28, 2010 at 2:05 pm By:

Gardasil approved to prevent anal cancer - ONA

oncologynurseadvisor.com — “The FDA has approved Gardasiil (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant, from Merck) for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18 in males and females ages 9--"26 years.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on December 23, 2010 at 5:13 pm By:

FDA Approves Gardasil For Anal Cancer Prevention

medicalnewstoday.com — “Gardasil is now approved as a vaccine for preventing anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18, in males and females from 9 to 26View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 23, 2010 at 3:05 pm By:

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

news-medical.net — “Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and femaView full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on December 23, 2010 at 10:35 am By:

HPV_Wisdom OrganizedWisdom HPV OW Health

Merck announces FDA approval for GARDASIL against HPV-related anal cancer: Merck, known as MSD outside the Unite... http://bit.ly/fqikJd

1 year ago...

Gardasil Approved to Prevent Anal Cancer

cancer.org — “The US Food and Drug Administration (FDA) has approved Gardasil to prevent anal cancer linked to certain types of the human papillomavirus (HPV).View full resource at cancer.org

  • View Related
  • Share

Most Recently Shared on December 22, 2010 at 10:33 pm By:

HPV_Wisdom OrganizedWisdom HPV OW Health

Gardasil Approved to Prevent Anal Cancer: The vaccine, made by Merck, targets HPV types 16 and 18, which are lin... http://bit.ly/h1Gcbm

1 year ago...

FDA: Gardasil approved to prevent anal cancer

fda.gov — “The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on December 22, 2010 at 10:33 pm By:

HPV_Wisdom OrganizedWisdom HPV OW Health

FDA: Gardasil approved to prevent anal cancer: The U.S. Food and Drug Administration today approved the vaccine ... http://bit.ly/gQ8bdo

1 year ago...

Advertisement